SCHEMBL4125403

SCHEMBL4125403

COc1ccc([C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
CYP2C19 P33261 1/20 0.60
LMNA P02545 2/20 0.53
SMPD1 P17405 2/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
PRSS3 P35030 1/20 0.44
POLB P06746 2/20 0.44
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4111932 0.82 MAOB (0.53) ALDH1A1HTTSMN1; SMN2MRGPRX4RXRA
SCHEMBL13612580 0.82 SMPD1 (0.48) ALDH1A1CYP2C19LMNASMPD1HDAC1
SCHEMBL3548995 0.80 SMPD1 (0.49) ALDH1A1CYP2C19LMNASMPD1HDAC1
SCHEMBL4131228 0.80 BRD4 (0.44) CYP2C19MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL13439291 0.78 SMPD1 (0.47) ALDH1A1CYP2C19LMNASMPD1HDAC1
SCHEMBL5429879 0.78 SMPD1 (0.47) ALDH1A1CYP2C19LMNASMPD1HDAC1
SCHEMBL7304672 0.77 ALDH1A1 (0.61) ALDH1A1CYP2C19LMNAKMT2AHTT
SCHEMBL7304664 0.77 ALDH1A1 (0.61) ALDH1A1CYP2C19LMNAKMT2AHTT
SCHEMBL5524550 0.76 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AF2
SCHEMBL5531247 0.76 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084641-B2 Organocataslysts and methods of use in chemical synthesis STC.UNM (US) 2011-12-27 US disclosed
US-8084641-B2 Organocataslysts and methods of use in chemical synthesis STC.UNM (US) 2011-12-27 US disclosed
US-20090088588-A1 Organocatalysts and methods of use in chemical synthesis REGENTS OF THE UNIVERSITY OF NEW MEXICO 2009-04-02 US disclosed
US-20090088588-A1 Organocatalysts and methods of use in chemical synthesis REGENTS OF THE UNIVERSITY OF NEW MEXICO 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088588-A1 Organocatalysts and methods of use in chemical synthesis ICMT, PPOX, CYP4F3 ALDH1A1 1418/4885CYP2C19 157/4885LMNA 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.